Geode Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Buy |
|
|||||
|
2025
Q1 | $36.4M | Buy |
|
|||||
|
2024
Q4 | $42.7M | Buy |
|
|||||
|
2024
Q3 | $42.7M | Sell |
|
|||||
|
2024
Q2 | $30.1M | Buy |
|
|||||
|
2024
Q1 | $25M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $5.11M | Buy |
|
|||||
|
2023
Q2 | $6.64M | Buy |
|
|||||
|
2023
Q1 | $5.17M | Buy |
|
|||||
|
2022
Q4 | $6.46M | Buy |
|
|||||
|
2022
Q3 | $5.15M | Buy |
|
|||||
|
2022
Q2 | $3.16M | Sell |
|
|||||
|
2022
Q1 | $4.25M | Buy |
|
|||||
|
2021
Q4 | $5.98M | Buy |
|
|||||
|
2021
Q3 | $4.03M | Buy |
|
|||||
|
2021
Q2 | $5.17M | Buy |
|